Ion mobility coupled
to mass spectrometry (IM-MS) is widely used
to study protein dynamics and structure in the gas phase. Increasing
the energy with which the protein ions are introduced to the IM cell
can induce them to unfold, providing information on the comparative
energetics of unfolding between different proteoforms. Recently, a
high-resolution cyclic IM-mass spectrometer (cIM-MS) was introduced,
allowing multiple, consecutive tandem IM experiments (IM
n
) to be carried out. We describe a tandem IM technique for defining
detailed protein unfolding pathways and the dynamics of disordered
proteins. The method involves multiple rounds of IM separation and
collision activation (CA): IM-CA-IM and CA-IM-CA-IM. Here, we explore
its application to studies of a model protein, cytochrome C, and dimeric
human islet amyloid polypeptide (hIAPP), a cytotoxic and amyloidogenic
peptide involved in type II diabetes. In agreement with prior work
using single stage IM-MS, several unfolding events are observed for
cytochrome C. IM
n
-MS experiments also show evidence of
interconversion between compact and extended structures. IM
n
-MS data for hIAPP shows interconversion prior to dissociation, suggesting
that the certain conformations have low energy barriers between them
and transition between compact and extended forms.
A novel mass spectrometry system is described here comprising
a
quadrupole-multireflecting time-of-flight design. The new multireflecting
time-of-flight analyzer has an effective path length of 48 m and employs
planar, gridless ion mirrors providing fourth-order energy focusing
resulting in resolving power over 200 000 fwhm and sub-ppm
mass accuracy. We show how these attributes are maintained with relatively
fast acquisition speeds, setting the system apart from other high
resolution mass spectrometers. We have integrated this new system
into both liquid chromatography-mass spectrometry and mass spectrometry
imaging workflows to demonstrate how the instrument characteristics
are of benefit to these applications.
Tandem mass spectrometry
of denatured, multiply charged high mass
protein precursor ions yield extremely dense spectra with hundreds
of broad and overlapping product ion isotopic distributions of differing
charge states that yield an elevated baseline of unresolved “noise”
centered about the precursor ion. Development of mass analyzers and
signal processing methods to increase mass resolving power and manipulation
of precursor and product ion charge through solution additives or
ion–ion reactions have been thoroughly explored as solutions
to spectral congestion. Here, we demonstrate the utility of electron
capture dissociation (ECD) coupled with high-resolution cyclic ion
mobility spectrometry (cIMS) to greatly increase top-down protein
characterization capabilities. Congestion of protein ECD spectra was
reduced using cIMS of the ECD product ions and “mobility fractions”,
that is, extracted mass spectra for segments of the 2D mobiligram
(m/z versus drift time). For small
proteins, such as ubiquitin (8.6 kDa), where mass resolving power
was not the limiting factor for characterization, pre-IMS ECD and
mobility fractions did not significantly increase protein sequence
coverage, but an increase in the number of identified product ions
was observed. However, a dramatic increase in performance, measured
by protein sequence coverage, was observed for larger and more highly
charged species, such as the +35 charge state of carbonic anhydrase
(29 kDa). Pre-IMS ECD combined with mobility fractions yielded a 135%
increase in the number of annotated isotope clusters and a 75% increase
in unique product ions compared to processing without using the IMS
dimension. These results yielded 89% sequence coverage for carbonic
anhydrase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.